{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:56:22Z","timestamp":1790394982863,"version":"4.1.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>\n                      Alport syndrome (AS) is a predominantly X-linked hereditary nephritis associated with high-tone, sensorineural deafness and characteristic eye signs. Clinical diagnostic criteria were defined in 1988. Most cases result from mutations in the X-linked collagen gene\n                      <jats:italic toggle=\"yes\">COL4A5<\/jats:italic>\n                      , with mutations in the autosomal genes\n                      <jats:italic toggle=\"yes\">COL4A3<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">COL4A4<\/jats:italic>\n                      on chromosome 2 accounting for the rest. Mutation analysis of\n                      <jats:italic toggle=\"yes\">COL4A5<\/jats:italic>\n                      with a combination of sequencing and multiplex ligation-dependent probe amplification has been available for several years. The objective of this study was to determine the utility of clinical diagnostic criteria in identifying patients likely to have a\n                      <jats:italic toggle=\"yes\">COL4A5<\/jats:italic>\n                      mutation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>\n                      Clinical information was available on 206 patients whose DNA was received for testing between 1994 and June 2008; predictive tests for a known familial mutation, samples from duplicate family members, and incompletely screened samples were excluded. One hundred and twenty-eight patients (62.1%) had a pathogenic\n                      <jats:italic toggle=\"yes\">COL4A5<\/jats:italic>\n                      mutation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mutation detection rate in families fulfilling zero, one, two, three, or four diagnostic criteria was 0%, 18%, 64%, 89%, and 81%, respectively. Sixty-seven percent of patients with\n                      <jats:italic toggle=\"yes\">COL4A5<\/jats:italic>\n                      mutations meeting only two diagnostic criteria had not had a complete clinical assessment. In two thirds of families meeting four diagnostic criteria without an identified\n                      <jats:italic toggle=\"yes\">COL4A5<\/jats:italic>\n                      mutation, autosomal inheritance was confirmed or suspected.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The authors recommend\n                      <jats:italic toggle=\"yes\">COL4A5<\/jats:italic>\n                      analysis in any patient meeting at least two clinical diagnostic criteria.\n                      <jats:italic toggle=\"yes\">COL4A3<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">COL4A4<\/jats:italic>\n                      analysis should be considered if a\n                      <jats:italic toggle=\"yes\">COL4A5<\/jats:italic>\n                      mutation is not detected and primarily if autosomal inheritance is suspected.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.00200110","type":"journal-article","created":{"date-parts":[[2010,9,30]],"date-time":"2010-09-30T22:02:04Z","timestamp":1285884124000},"page":"198-203","source":"Crossref","is-referenced-by-count":35,"title":["The Value of Clinical Criteria in Identifying Patients with X-Linked Alport Syndrome"],"prefix":"10.2215","volume":"6","author":[{"given":"Helen","family":"Hanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Storey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Pagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Flinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20230811","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/bmj.1.3454.504","article-title":"Hereditary familial congenital haemorrhagic nephritis","volume":"1","author":"Alport","year":"1927","journal-title":"BMJ"},{"key":"R2-27-20230811","first-page":"161","article-title":"A heredo-familial syndrome characterized by renal disease, inner ear deafness, and ocular changes","volume":"47","author":"Sohar","year":"1954","journal-title":"Harefuah"},{"key":"R3-27-20230811","first-page":"203","article-title":"Hereditary nephropathy (Alport syndrome): Correlation of clinical data with glomerular basement membrane alterations","volume":"13","author":"Rumpelt","year":"1980","journal-title":"Clin Nephrol"},{"key":"R4-27-20230811","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/ndt\/11.supp7.21","article-title":"Report on management of renal failure in Europe, XXVI: 1995. The child\u2013adult interface: A report on Alport's syndrome, 1975\u20131993. The ERA-EDTA Registry","volume":"11","author":"Rigden","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"R5-27-20230811","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(88)90753-2","article-title":"Genetics of classic Alport's syndrome","volume":"2","author":"Flinter","year":"1988","journal-title":"Lancet"},{"key":"R6-27-20230811","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1093\/ndt\/gfl472","article-title":"Hearing in renal failure","volume":"21","author":"Thodi","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R8-27-20230811","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","article-title":"X-linked Alport syndrome: Natural history in 195 families and genotype-phenotype correlations in males","volume":"11","author":"Jais","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R9-27-20230811","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1046\/j.1523-1755.1999.00357.x","article-title":"Identification of COL4A5 defects in Alport's syndrome by immunohistochemistry of skin","volume":"55","author":"Van Der Loop","year":"1999","journal-title":"Kidney Int"},{"key":"R10-27-20230811","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000059891","article-title":"X\u2013linked Alport syndrome with normal distribution of collagen IV alpha chains in epidermal basement membranes","volume":"122","author":"Naito","year":"1997","journal-title":"Contrib Nephrol"},{"key":"R12-27-20230811","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1681\/ASN.V9122291","article-title":"High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201101000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:40:12Z","timestamp":1786369212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201101000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.00200110","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}